WALTHAM, Mass.– Thermo Fisher Scientific Inc., the world leader in serving science, has completed its acquisition of MarqMetrix, a privately held developer of Raman-based spectroscopy solutions for in-line measurement. The terms of the deal were not disclosed.
Based in Seattle, Washington, MarqMetrix provides innovative and fit-for-purpose in-line Process Analytical Technology (PAT), offering customers a simplified method to make precise and accurate measurements throughout the manufacturing process for a wide range of applications, including biopharma and pharmaceuticals, oil and gas, and chemicals and polymers.
“The acquisition of MarqMetrix is an excellent strategic fit for Thermo Fisher and adds highly complementary Raman-based in-line PAT to Thermo Fisher’s portfolio,” said Miguel Faustino, President, Chemical Analysis, Thermo Fisher. “MarqMetrix will add expanded and differentiated capabilities to Thermo Fisher’s leading portfolio of analytical solutions to address customer requirements for real-time measurement and process control of critical manufacturing process parameters that affect quality. We look forward to welcoming the MarqMetrix team to Thermo Fisher.”
MarqMetrix has approximately 30 employees based in the United States. MarqMetrix will become part of Thermo Fisher’s Analytical Instruments segment.
